Growth Metrics

Boston Scientific (BSX) Income towards Parent Company (2016 - 2026)

Boston Scientific's Income towards Parent Company history spans 18 years, with the latest figure at $1.3 billion for Q1 2026.

  • On a quarterly basis, Income towards Parent Company rose 99.11% to $1.3 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $3.6 billion, a 75.75% increase, with the full-year FY2025 number at $2.9 billion, up 56.66% from a year prior.
  • Income towards Parent Company hit $1.3 billion in Q1 2026 for Boston Scientific, up from $670.0 million in the prior quarter.
  • Over the last five years, Income towards Parent Company for BSX hit a ceiling of $1.3 billion in Q1 2026 and a floor of $111.0 million in Q1 2022.
  • Historically, Income towards Parent Company has averaged $492.3 million across 5 years, with a median of $493.0 million in 2024.
  • Biggest five-year swings in Income towards Parent Company: crashed 67.45% in 2022 and later skyrocketed 257.45% in 2023.
  • Tracing BSX's Income towards Parent Company over 5 years: stood at $141.0 million in 2022, then skyrocketed by 257.45% to $504.0 million in 2023, then rose by 11.51% to $562.0 million in 2024, then increased by 19.22% to $670.0 million in 2025, then soared by 99.7% to $1.3 billion in 2026.
  • Business Quant data shows Income towards Parent Company for BSX at $1.3 billion in Q1 2026, $670.0 million in Q4 2025, and $756.0 million in Q3 2025.